Navigation Links
Anti-Glycolytic Therapy Proved to be Effective Against Tumors

By targeting on the energy producing cellular glycolytic pathway and knocking down the pathway enzyme-LDHA, a team of researchers //at the Harvard Medical School (HMS) have made the fast-growing breast cancer cells under control.

In an animal study using mice, scientists have noticed that control ones carrying tumor cells with an intact glycolytic pathway did not survived beyond 10 weeks but in contrast about 8 per cent LDHA-deficient mice outlived the four-month experiment period.

‘This is an exciting contribution that reveals a surprising Achilles heel in cancer cells. It also adds to our sense of opportunity for new avenues of cancer therapeutics,’ said Stuart Schrieber, Morris Loeb professor and chair of the Department of Chemistry and Chemical Biology at Harvard University.

As a tumor grows, cells crowd one another and may be cut off from oxygen-carrying blood vessels--a distinct disadvantage since most cells require oxygen to produce the bulk of their energy-storing adenosine triphosphate (ATP). In the 1920s, Otto Warburg proposed that some cancer cells evolved the ability to switch over to an ancient, oxygen-free route, the glycolytic pathway. What is more, they continue to use this pathway even when access to oxygen is restored. Though the so-called Warburg effect has since been confirmed, the role played by glycolysis in cancer has been largely ignored. Few have attempted to attack specific points along the glycolytic pathway to gain a therapeutic effect.

‘LDHA could be one weak point that we could attack but maybe, if we understand exactly all the steps involved, we could devise alternative strategies to attack the same pathway,’ said Fantin, who was an HMS research fellow in genetics when the study was performed. She is currently a research scientist at Merck & Co.

What may excite the growing band of researchers who are studying the Warburg effect, and cancer metabolism more generally, is the way the study
'"/>




Page: 1 2 3

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ield University are in the hope of using stem cell... by creating embryonic stem cells // from the inne...he researchers have tried to regenerate the damage... make them divide into required cell, which has le...
...ry popular drink in Europe and more so in Germany....ave manufactured a healthy beer called karla //, w...nd also prevent cancer. The beer is made form her...oya extract, folic acid and vitamins. It is also w...
...ealed that a IQ level is directly linked to growth...s directly linked to the IQ level of the child, ac...rs. This study also reveals that the children who ... comparison to shorter children. If growth hormone...
... AIDS Day, the Vatican has condemned a culture of ...rted that the best way to prevent the spread // o...icted to marriage and intensifying the strength of...ternational day of action on HIV and AIDS, is comm...
Other Medicine News:
(Date:9/4/2008)...ime PCR testing for the diagnostic ...4 /- The U.S. Food & Drug,Administrat...) HBV Test,the first assay for quantitating Hepat...s Roche,s real-time PCR technology to quantify the...ood. Doctors may use viral load,testing results to...
(Date:9/4/2008)...Newswire/ -- Axentis Pharma AG has,initiated a cli...erability,of a new therapeutic formulation for the... fibrosis patients. The new formulation allows an,...ctly to the site of,infection. The forthcoming tri...doses of the new drug. Initial results are expecte...
(Date:9/3/2008)...RNewswire-FirstCall/ --,Pharmaceutical company Pha...at it has enrolled the first subject into its seco...hitol in cystic fibrosis sufferers., The Phase 3 ...rth,America, Argentina and Germany, and is the fin...o market Bronchitol for cystic fibrosis in the,Uni...
(Date:9/3/2008)...r Disease Awareness Month, CHARLOTTESVILLE, Va., ...LLC, a clinical-stage drug-development company com...medical needs, announced today that it has begun,t...f its lead drug,candidate trans sodium crocetinate...linicaltrials.gov Website, is investigating TSC as...
Breaking Medicine Technology:FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved 779 1Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved 779 2Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved 779 3Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 1Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 2Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 3Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 4Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 5Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 6AtriCure Reports Third Quarter 2007 Financial Results 5711 1AtriCure Reports Third Quarter 2007 Financial Results 5711 2AtriCure Reports Third Quarter 2007 Financial Results 5711 3AtriCure Reports Third Quarter 2007 Financial Results 5711 4AtriCure Reports Third Quarter 2007 Financial Results 5711 5AtriCure Reports Third Quarter 2007 Financial Results 5711 6AtriCure Reports Third Quarter 2007 Financial Results 5711 7AtriCure Reports Third Quarter 2007 Financial Results 5711 8AtriCure Reports Third Quarter 2007 Financial Results 5711 9Synchrotron radiation illuminates how babies protective bubble bursts 1711 1Synchrotron radiation illuminates how babies protective bubble bursts 1711 2
...IEGO--(BUSINESS WIRE)--Mar 26, 2007 - Inovio Biome...velopment of DNA vaccines and,a novel solid tumor ... of Virology has published a scientific paper prep...ding results from a,non-human primate study of an ...using Inovio Biomedical,s electroporation technolo...
...ple Mechanisms for Panzem NCD, MKC-1, and ENMD-119...e, ROCKVILLE, Md., March 26, 2007 /PRNewswire-Firs...eutical company developing,therapeutics for the tr... announced the presentation of comparative mechani...e compounds Panzem(R), MKC-1,and ENMD-1198. These ...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 2Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 4EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 2EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 3EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 4
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: